Sciences de la vie

Overview


Chambers USA 2018, Client Quote

La demande du marché pour les produits et services des sciences de la vie ne cesse de croître. Parallèlement, le secteur traverse une période particulièrement mouvementée. La réforme des soins de santé crée de nouveaux prix et pèse sur les payeurs ; les autorités réglementaires fédérales et nationales ainsi que les agents chargés de l’application des lois intensifient leur contrôle, et les sociétés pharmaceutiques rencontrent des difficultés liées au développement des produits. L’activité évolue en faveur de marchés émergents, et l’externalisation est une composante de plus en plus importante du développement de la recherche et de la chaîne d’approvisionnement.

Show More

Results


  • Amgen Inc., la plus grande société de biotechnologie du monde, en faveur de qui nous avons obtenu le rejet, dans le cadre d’une action en nom collectif présentant des enjeux de taille dans une affaire d’antitrust, de la requête introduite devant le troisième circuit de la Cour d’appel des États-Unis (US Court of Appeals for the Third Circuit) par Warren General Hospital au motif qu’Amgen avait illégalement lié la vente de ses médicaments phares (Neulasta® et Neupogen®) à celle d’un de ses autres médicaments.
  • Nexus Pharmaceuticals, Inc., une société spécialisée dans le développement de médicaments génériques injectables et ophtalmologiques basée aux États-Unis, dans le cadre de la vente de nombreuses ANDA en faveur de Rising Pharmaceuticals, Inc.

Show More

People


McDermott’s Life Sciences Team will get you closer to your goals. Composed of top lawyers with demonstrated strength across intellectual property, regulatory, transactional and litigation law, we’re a purpose-built team of thought leaders united by a passion for our work.

Sciences de la vie

Insights & Events / Media

Speaking Engagements / November 4, 2019

Shanghai, China / McDermott Event / November 12, 2019

Cambridge, MA / McDermott Event / October 16, 2019

Cambridge, MA / McDermott Event / October 15-16, 2019

Philadelphia, PA / Speaking Engagements / May 31 - June 1, 2019

IP Update / May 2019

Lincolnshire, IL / McDermott Event / May 14, 2019

IP Update / April 2019

Boston, Massachusetts / Speaking Engagements / October 17, 2018

San Francisco, California / McDermott Event / January 7-9, 2019

Scottsdale, Arizona / Speaking Engagements / March 25–28, 2018

Boston, Massachusetts / Speaking Engagements / May 31, 2018

Pharm. Ind. 80, Issue 10 / November 2018

New York, New York / Speaking Engagements / November 5, 2018

IP Update / October 2018

Boston, Massachusetts / McDermott Event / October 10, 2018

Cambridge, Massachusetts / McDermott Event / October 9, 2018

Utica, New York / Speaking Engagements / September 27, 2018

Paris, France / McDermott Event / September 25, 2018

Cambridge, Massachusetts / McDermott Event / September 12, 2018

Boston, Massachusetts / Speaking Engagements / August 20, 2018

/ July 2018

Paris, France / McDermott Event / July 10, 2018

Paris, France / McDermott Event / June 28, 2018

On the Subject / June 15, 2018

Copenhagen, Denmark / McDermott Event / June 13, 2018

Copenhagen, Denmark / Speaking Engagements / June 12, 2018

Copenhagen, Denmark / Speaking Engagements / June 12, 2018

Copenhagen, Denmark / Speaking Engagements / June 11, 2018

Boston, Massachusetts / Speaking Engagements / June 5, 2018

Boston, Massachusetts / Speaking Engagements / June 4-7, 2018

Boston, Massachusetts / Speaking Engagements / June 4, 2018

Boston, Massachusetts / Speaking Engagements / June 3, 2018

Boston, Massachusetts / Speaking Engagements / June 1, 2018

Voit, Compliance- und Regulierungsfragen / Naturheilkunde und Innovation, 1st Edition 2018 / May, 2018

Princeton, New Jersey / Speaking Engagements / May 6, 2018

Washington, District of Columbia / Speaking Engagements / May 3-4, 2018

Boston, Massachusetts / Speaking Engagements / May 3, 2018

Boston, Massachusetts / Speaking Engagements / May 3, 2018

Waltham, Massachusetts / Speaking Engagements / May 3, 2018

Boston, Massachusetts / Speaking Engagements / April 26, 2018

Special Report / April 25, 2018

Washington, District of Columbia / Speaking Engagements / April 23-25, 2018

Paris, France / Speaking Engagements / April 4, 2018

/ March 2018

AHLA (American Health Lawyers Association) / March 2018

San Francisco, California / Speaking Engagements / January 9, 2018

San Francisco, California / McDermott Event / January 9, 2018

San Francisco, California / McDermott Event / January 8, 2018

San Francisco, California / McDermott Event / January 8, 2018

IP Update / December 2017

Cambridge, Massachusetts / Speaking Engagements / December 11, 2017

IP Update / November 2017

GesR, Issue 11 / November 2017

Patient Individual Blister of Medicines in the Care of the Elderly

Cambridge, Massachusetts / Speaking Engagements / October 4, 2017

Cambridge, Massachusetts / McDermott Event / October 4, 2017

Life Sciences Symposium / October 4, 2017

On the Subject / September 29, 2017

Munich, Germany / McDermott Event / September 19, 2017

PharmaR, Issue 4 / April 30, 2017

Re-Introduction of the Prohibition of Online Sales of Rx-Drugs – Admissible Under Constitutional ...

/ March 2017

Webinar / McDermott Event / March 1, 2017

Redefining Early Stage Investments (RESI) Conference / January 2017

On the Subject / January 31, 2017

San Francisco, California / McDermott Event / January 10, 2017

On the Subject / January 22, 2015

Pharmind, Issue 11 / November 2014

New Developments On Combating Corruption and Compliance In Healthcare

International Law Office Newsletter, Germany / October 29, 2014

German Perspective on New EU Clinical Trials Regulation

International Law Office Newsletter, Germany / June 18, 2014

Pricing for New Innovative Drugs – Public Payers Attempt New Approach

Law360 / April 1, 2014

How Changes To 'Dear Doctor Letters' Will Impact Industry

International Law Office Newsletter, Germany / February 26, 2014

Generic Drug and API Producers Deal with the Bolar Exemption

International Law Office Newsletter, Germany / February 19, 2014

Yet another Health Reform and Seizure of Retiring Doctors' Practices

Healthcare Marketing - Das Fachmagazin für Gesundheitsmarken, Issue 1-2 / January 2014

Patent Expirations: Generic Drugs and Active Ingredient Producers from the Perspective of ...

Publications / January 1, 2013

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

... 39